Last reviewed · How we verify
NEOSAXITOXIN
At a glance
| Generic name | NEOSAXITOXIN |
|---|---|
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study in Healthy Male Volunteers to Investigate the Safety and Tolerability of a Single Dose of Neosaxitoxin Alone and in Combination With Bupivacaine (With and Without Epinephrine) for Brachial Plexus Blockade (PHASE1)
- Safety Study of Long-Acting Local Anesthetic (PHASE1)
- Local Anesthetic Properties of Neosaxitoxin (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NEOSAXITOXIN CI brief — competitive landscape report
- NEOSAXITOXIN updates RSS · CI watch RSS